195 related articles for article (PubMed ID: 34861059)
21. Association between elevated plasma microRNA-223 content and severity of coronary heart disease.
Guo JF; Zhang Y; Zheng QX; Zhang Y; Zhou HH; Cui LM
Scand J Clin Lab Invest; 2018 Sep; 78(5):373-378. PubMed ID: 29888618
[TBL] [Abstract][Full Text] [Related]
22. Correlation of Long Non-coding RNA LncRNA-FA2H-2 With Inflammatory Markers in the Peripheral Blood of Patients With Coronary Heart Disease.
Guo F; Sha Y; Hu B; Li G
Front Cardiovasc Med; 2021; 8():682959. PubMed ID: 34235188
[No Abstract] [Full Text] [Related]
23. Serum ITIH4 in coronary heart disease: a potential anti-inflammatory biomarker related to stenosis degree and risk of major adverse cardiovascular events.
Huo Y; Lai Y; Feng Q; Wang Q; Li J
Biomark Med; 2022 Dec; 16(18):1279-1288. PubMed ID: 36891881
[TBL] [Abstract][Full Text] [Related]
24. Increased levels of markers of vascular inflammation in patients with coronary heart disease.
Schumacher A; Seljeflot I; Sommervoll L; Christensen B; Otterstad JE; Arnesen H
Scand J Clin Lab Invest; 2002; 62(1):59-68. PubMed ID: 12002414
[TBL] [Abstract][Full Text] [Related]
25. Circulating HDAC4 reflects lipid profile, coronary stenosis and inflammation in coronary heart disease patients.
Guo Z; Wu Y; Feng Q; Wang C; Wang Z; Zhu Y; Lu X; Chen W; Yang Q; Huo Y
Biomark Med; 2023 Jan; 17(1):41-49. PubMed ID: 37013891
[TBL] [Abstract][Full Text] [Related]
26. Circulating MiR-146a May be a Potential Biomarker of Coronary Heart Disease in Patients with Subclinical Hypothyroidism.
Quan X; Ji Y; Zhang C; Guo X; Zhang Y; Jia S; Ma W; Fan Y; Wang C
Cell Physiol Biochem; 2018; 45(1):226-236. PubMed ID: 29357324
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease.
Porsch-Oezçueruemez M; Kunz D; Kloer HU; Luley C
J Am Coll Cardiol; 1999 Dec; 34(7):1995-2001. PubMed ID: 10588215
[TBL] [Abstract][Full Text] [Related]
28. Serum YKL-40 in coronary heart disease: linkage with inflammatory cytokines, artery stenosis, and optimal cut-off value for estimating major adverse cardiovascular events.
Song M; Zhang G; Shi H; Zhu E; Deng L; Shen H
Front Cardiovasc Med; 2023; 10():1242339. PubMed ID: 38028459
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-155 (miR-155) as an accurate biomarker of periodontal status and coronary heart disease severity: a case-control study.
Daily ZA; Al-Ghurabi BH; Al-Qarakhli AMA; Moseley R
BMC Oral Health; 2023 Nov; 23(1):868. PubMed ID: 37974134
[TBL] [Abstract][Full Text] [Related]
30. Modulation of Vascular Smooth Muscle Cell Multiplication, Apoptosis, and Inflammatory Damage by miR-21 in Coronary Heart Disease.
Liu W; Li Y; Zhao D
Comput Math Methods Med; 2021; 2021():6942699. PubMed ID: 34873417
[TBL] [Abstract][Full Text] [Related]
31. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
[TBL] [Abstract][Full Text] [Related]
32. miR-126 in Peripheral Blood Mononuclear Cells Negatively Correlates with Risk and Severity and is Associated with Inflammatory Cytokines as well as Intercellular Adhesion Molecule-1 in Patients with Coronary Artery Disease.
Wu H; Zhang J
Cardiology; 2018; 139(2):110-118. PubMed ID: 29316562
[TBL] [Abstract][Full Text] [Related]
33. Role of Serum miR-181b, Proinflammatory Cytokine, and Adhesion Molecules in Behçet's Disease.
El Boghdady NA; Shaker OG
J Interferon Cytokine Res; 2019 Jun; 39(6):347-354. PubMed ID: 30848985
[TBL] [Abstract][Full Text] [Related]
34. [Analysis on the association of single nucleotide polymorphism in the promoter region of pre-miR-320b-2 with coronary heart disease risk and factors influencing circulating microRNA-320b level].
Feng J; Huang S; He M; Dai X; Li J; Deng Q; Qiu G; Yang B; Wu T
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Oct; 48(10):893-9. PubMed ID: 25573129
[TBL] [Abstract][Full Text] [Related]
35. Predictive Effects of Circulating miR-221, miR-130a and miR-155 for Coronary Heart Disease: A Multi-Ethnic Study in China.
Jia QW; Chen ZH; Ding XQ; Liu JY; Ge PC; An FH; Li LH; Wang LS; Ma WZ; Yang ZJ; Jia EZ
Cell Physiol Biochem; 2017; 42(2):808-823. PubMed ID: 28628920
[TBL] [Abstract][Full Text] [Related]
36. The potential of microRNA-126 in predicting disease risk, mortality of sepsis, and its correlation with inflammation and sepsis severity.
Lin R; Hu H; Li L; Chen G; Luo L; Rao P
J Clin Lab Anal; 2020 Sep; 34(9):e23408. PubMed ID: 32484987
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA MALAT1/microRNA 125a axis presents excellent value in discriminating sepsis patients and exhibits positive association with general disease severity, organ injury, inflammation level, and mortality in sepsis patients.
Liu W; Geng F; Yu L
J Clin Lab Anal; 2020 Jun; 34(6):e23222. PubMed ID: 32309886
[TBL] [Abstract][Full Text] [Related]
38. Dysregulated circulating microRNA-126 in chronic obstructive pulmonary disease: linkage with acute exacerbation risk, severity degree, and inflammatory cytokines.
Wang C; Feng D; Dong S; He R; Fan B
J Clin Lab Anal; 2022 Mar; 36(3):e24204. PubMed ID: 35064606
[TBL] [Abstract][Full Text] [Related]
39. Circulating microRNA profiles based on direct S-Poly(T)Plus assay for detection of coronary heart disease.
Su M; Niu Y; Dang Q; Qu J; Zhu D; Tang Z; Gou D
J Cell Mol Med; 2020 Jun; 24(11):5984-5997. PubMed ID: 32343493
[TBL] [Abstract][Full Text] [Related]
40. Alteration in microRNA-155 level correspond to severity of coronary heart disease.
Qiu XK; Ma J
Scand J Clin Lab Invest; 2018 May; 78(3):219-223. PubMed ID: 29411649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
